Source comparison
NAD+ precursors vs peptides
Direct NAD+ boosting approaches: NAD+ precursors (not peptides): NMN (Nicotinamide Mononucleotide) NR (Nicotinamide Riboside) Niacin (Nicotinic Acid, Vitamin B3) Directly convert to NAD+ in body Oral supplementation works Not peptides - small molecules NAD+ pr
This comparison does not assign a generated winner or score.
- Direct NAD+ boosting approaches:
- NAD+ precursors (not peptides):
- NMN (Nicotinamide Mononucleotide)
- NR (Nicotinamide Riboside)
- Niacin (Nicotinic Acid, Vitamin B3)
- Directly convert to NAD+ in body
- Oral supplementation works
- Not peptides - small molecules
- NAD+ precursor comparison:
- Precursor
- Mechanism
- Dose
- Cost/Month
- Efficacy
- NMN
- Direct conversion to NAD+
- 250-1,000mg daily
- $50-150
- Good evidence, popular
- NR
- Converts to NMN then NAD+
- 250-500mg daily
- $40-100
- Good evidence, well-studied
- Niacin
- NAD+ precursor (ancient)
- 100-500mg daily
- $10-20
- Proven but causes flushing
- Peptides vs NAD+ precursors:
- NAD+ precursors (NMN/NR):
- Directly boost NAD+ levels
- Measurable NAD+ increase in blood
- Oral supplementation convenient
- Well-tolerated (minimal sides)
- Affordable ($40-150/month)
- Evidence: Moderate to good
- Mitochondrial peptides (SS-31, etc.):
- Optimize mitochondrial function
- Don't directly increase NAD+ (work with existing)
- Require injection
- Generally well-tolerated
- Expensive ($200-400/month)
- Evidence: Limited human data
- Which approach better?
- Goal
- Best Approach
- Rationale
- Directly boost NAD+
- NMN or NR
- Direct precursors increase levels
- Optimize mitochondria
- SS-31 or MOTS-c
- Peptides target mitochondrial function
- Budget-friendly
- NMN/NR
- Much cheaper than peptides
- Maximum effect
- Combine both
- Synergistic (NMN + SS-31)
- Convenient
- Oral vs injection
- Combining NAD+ precursors + peptides:
- NMN provides NAD+ building blocks
- SS-31 optimizes mitochondria to use NAD+
- Potentially synergistic
- Comprehensive energy optimization
- Expensive but thorough